— PAPZIMEOS approval marks a historic milestone for the RRP patient community as the first and only FDA-approved therapy for the treatment of adults with RRP — PAPZIMEOS received full approval from the FDA for the treatment of adults with RRP; a confirmatory clinical trial is no longer required — RRP is a rare, debilitating, […]

Beef. It's What's For Dinner. teams up with Little League®to share home run recipes sure to keep young athletes fueled and in the game. Families may be preparing for back-to-school time, but that doesn't mean summer festivities, or summer sports, are over. As busy schedules and temperatures continue to rise, now more than ever, it's

190 MW solar and battery storage project is now online providing reliable power for Jicarilla Apache Nation, as well as municipalities and electric coops National Renewable Solutions(NRS), a US-based renewable energy developer, announced today that Shallow Basket Energy is now operating. The 140 MWac solar energy and 50 MW battery storage project, located in Rio

Brand's first-ever multilingual albums and expanded experiences for generations of fans Chuck E. Cheese is expanding its global musical footprint with the launch of its first-ever full-length albums in Spanish and Arabic, now available for streaming or download on major music platforms globally, including on Amazon Music, Apple Music, Spotify and YouTube. https://mma.prnewswire.com/media/1166155/Chuck_E_Cheese_Logo.jpg The two

Kestrel Group Ltd (NASDAQ: KG) (“KG” or the “Company”), today announced its financial results for the second quarter ended June 30, 2025. For further details regarding the Company's financial performance and condition, please refer to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, filed with the U.S. Securities and Exchange

SineuGene Therapeutics Co., Ltd. (“SineuGene”), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, announced today that China's National Medical Products Administration (NMPA) has cleared the Investigational New Drug (IND) application for SNUG01, a groundbreaking gene therapy product for amyotrophic lateral sclerosis (ALS). This milestone follows a prior clearance of SNUG01's IND

Flowers Foods, Inc. (NYSE:FLO) today reported financial results for the company's 12-week second quarter ended July 12, 2025. https://mma.prnewswire.com/media/1743440/Flowers_Foods_Logo.jpg Second Quarter Summary: Compared to the prior year second quarter where applicable — Net sales(1) increased 1.5% to $1.243 billion as the Simple Mills acquisition benefit more than offset pricing/mix and volume declines. — Net income

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates GlobeNewswire August 15, 2025 Patient enrollment for our ongoing Phase-3 clinical trial of SGT-610 for Gorlin Syndrome has been completed; top-line results are expected in the fourth quarter of 2026 Phase-1b proof-of-concept clinical trial of SGT-210 for Darier disease is ongoing Sol-Gel and Mayne

Abaxx Provides Q2 2025 Corporate Update GlobeNewswire August 15, 2025 TORONTO, Aug. 15, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company“), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing“), and producer

Next Hydrogen Reports Q2 2025 Financial Results GlobeNewswire August 15, 2025 MISSISSAUGA, Ontario, Aug. 15, 2025 (GLOBE NEWSWIRE) — Next Hydrogen Solutions Inc. (the “Company” or “Next Hydrogen”) (TSXV:NXH, OTC:NXHSF), a designer and manufacturer of electrolyzers, is pleased to report its financial results for the second quarter ended June 30, 2025. “We achieved a major